drugset / Trial / NCT02735070

Study Comparing Coristina® D to Resfenol® in the Symptomatic Treatment of Common Cold

NCT02735070

RandomizedParallel-groupSingle-blindTreatment

Summary

The primary objective of this study is to evaluate the non-inferiority of Coristina® d in the symptomatic treatment of the common cold compared to Resfenol® comparator.

Timeline

Start
2016-09
Primary completion
2017-03
Completion
2017-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 400 mg Oral
Subject Aspirin Small molecule 400 mg Oral
Subject Caffeine Small molecule 30 mg Oral
Comparator Chlorpheniramine Unknown 4 mg Oral
Subject Dexchlorpheniramine Unknown 1 mg Oral
Comparator Phenylephrine Small molecule 4 mg Oral
Comparator Phenylephrine Small molecule 10 mg Oral

Indications

No indication recorded.